Recombinant proteins for neurodegenerative diseases: the delivery issue
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 24 (9) , 533-540
- https://doi.org/10.1016/s0166-2236(00)01899-3
Abstract
No abstract availableKeywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
This publication has 59 references indexed in Scilit:
- Implantation of Bioactive Growth Factor-Secreting Rods Enhances Fetal Dopaminergic Graft Survival, Outgrowth Density, and Functional Recovery in a Rat Model of Parkinson's DiseaseExperimental Neurology, 2000
- Lentiviral Vectors: Regulated Gene ExpressionMolecular Therapy, 2000
- New Animal Models for Parkinson's DiseaseCell, 2000
- Progress in the clinical and molecular genetics of familial parkinsonismneurogenetics, 2000
- Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's DiseaseHuman Gene Therapy, 2000
- Epi-Arachnoidal Drug Deposit: A Rare Complication of Intrathecal Drug TherapyJournal of Pain and Symptom Management, 1999
- Recent Insights into the Molecular Pathogenesis of Huntington DiseaseSeminars in Neurology, 1999
- Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's diseaseBrain Research, 1995
- Transplantation to the rat brain of human neural progenitors that were genetically modified using adenovirusesNature Genetics, 1995
- Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopaNeuron, 1991